Evidence map›Paper›PMID 28264985›Full record

ArticleJournal of medical genetics2017

KCNQ1 p.L353L affects splicing and modifies the phenotype in a founder population with long QT syndrome type 1.

Jamie D Kapplinger, Anders Erickson, Sirisha Asuri, David J Tester, Sarah McIntosh, Charles R Kerr, Julie Morrison, Anthony Tang, Shubhayan Sanatani, Laura Arbour and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. A mild phenotype associated withFrontiers in pediatrics · 2024
    Article
  4. Article
  5. Circulation. Genomic and precision medicine · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jamie D KapplingerMayo Medical School, Mayo Clinic, Rochester, Minnesota, USA.
Anders EricksonDivision of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
Sirisha AsuriDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
David J TesterDivision of Heart Rhythm Services, Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Sarah McIntoshDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Charles R KerrDivision of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
Julie MorrisonGitxsan Health Society, Hazelton, British Columbia, Canada.
Anthony TangDepartment of Medicine, University of Western Ontario, London, Ontario, Canada.
Shubhayan SanataniDivision of Cardiology, Department of Pediatrics, University of British Columbia, BC Children's Hospital, Vancouver, British Columbia, Canada.
Laura ArbourDivision of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada.
Michael J AckermanMayo Medical School, Mayo Clinic, Rochester, Minnesota, USA.
University of British Columbia · CAWinnMed · USUniversity of Victoria · CAVancouver Native Health Society · CAWestern University · CA

Funding

Predoctoral Training Program in Molecular PharmacologyT32GM072474 · NIGMS · MAYO CLINIC ROCHESTER · PI KARNITZ, LARRY M · 2005 to 2020
$2.4M
Allele-specific RNA Interference Targeting Synonymous Polymorphisms in KCNQ1 as a Novel Therapeutic for Long QT SyndromeF30HL127904 · NHLBI · MAYO CLINIC ROCHESTER · PI KAPPLINGER, JAMIE DUANE · 2015 to 2016
$93k
NHLBI NIH HHS F30 HL127904NIGMS NIH HHS T32 GM072474
6 · The paper itself

Abstract

backgroundVariable expressivity and incomplete penetrance between individuals with identical long QT syndrome (LQTS) causative mutations largely remain unexplained. Founder populations provide a unique opportunity to explore modifying genetic effects. We examined the role of a novel synonymous

methods419 adults were genotyped for p.V205M, p.L353L and a previously described QTc modifier (

resultsFor women and men, respectively, p.L353L alone conferred a 10.0 (p=0.064) ms and 14.0 (p=0.014) ms increase in QTc and in men only a significant interaction effect in combination with the p.V205M (34.6 ms, p=0.003) resulting in a QTc of ∼500 ms. The mechanism of p.L353L's effect was attributed to approximately threefold increase in exon 8 exclusion resulting in ∼25% mutant transcripts of the total

conclusionsOur results provide the first evidence that synonymous variants outside the canonical splice sites in

Indexed as

Arrhythmias, CardiacExonsFemaleGenotypeHumansKCNQ1 Potassium ChannelMaleMutationPhenotypeRNA SplicingRomano-Ward SyndromeKCNQ1 Potassium ChannelKCNQ1 protein, humanexon skippingFirst Nations<i>KCNQ1</i>long QT syndromemodifier

Identifiers

PMID28264985
PMCPMC5502312
OpenAlexW2592552534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.